Fluorodopa Pet
Fluorodopa PET is a positron emission tomography imaging technique that utilizes radiolabeled L-dihydroxyphenylalanine to selectively visualize and localize neuroendocrine tumors, particularly those of neural crest origin such as pheochromocytomas, by targeting their enhanced catecholamine synthesis pathway.
294
Publications
23K
Citations
1.5K
Authors
454
Institutions
Publications per year
2017–2026
42
Variants
18F-dopa PetFluorodopa Positron Emission Tomography
Parents
294
Jeffrey H. Kordower, Thomas B. Freeman, Barry Snow et al. · New England Journal of Medicine · 1995 · 869 citations
Henri Timmers, Clara C. Chen, Jorge A. Carrasquillo et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 393 citations · Full text
1–5 of 294
1.5K
15
h-index
14
h-index
13
h-index
13
h-index
12
h-index
1–5 of 1.5K
454
National Institutes of Health
Bethesda, United States
26 h-index
150 publications
15.4K citations

University of British Columbia
Vancouver, Canada
21 h-index
100 publications
11.5K citations
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Bethesda, United States
18 h-index
58 publications
6.4K citations
University of California, Los Angeles
Los Angeles, United States
18 h-index
139 publications
9.2K citations
National Institute of Neurological Disorders and Stroke
Bethesda, United States
16 h-index
56 publications
6.5K citations
National Institutes of Health Clinical Center
Bethesda, United States
16 h-index
40 publications
3.5K citations
Aix-Marseille Université
Marseille, France
15 h-index
65 publications
4.5K citations
Inserm
Paris, France
14 h-index
46 publications
3.4K citations
1–8 of 454
Repository · 24 publications · 1.4K citations
20
h-index
16 publications · 4.1K citations
16
h-index
15 publications · 895 citations
14
h-index
14 publications · 1K citations
14
h-index
12 publications · 1K citations
12
h-index
1–5